These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9773787)
21. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers. Schernthaner-Reiter MH; Adams D; Trivellin G; Ramnitz MS; Raygada M; Golas G; Faucz FR; Nilsson O; Nella AA; Dileepan K; Lodish M; Lee P; Tifft C; Markello T; Gahl W; Stratakis CA Eur J Pediatr; 2016 May; 175(5):727-33. PubMed ID: 26795631 [TBL] [Abstract][Full Text] [Related]
22. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus. Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297 [TBL] [Abstract][Full Text] [Related]
23. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones. Cheong HI; Cho HY; Park HW; Ha IS; Choi Y Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330 [TBL] [Abstract][Full Text] [Related]
24. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Cheong HI; Park HW; Ha IS; Moon HN; Choi Y; Ko KW; Jun JK Nephron; 1997; 75(4):431-7. PubMed ID: 9127330 [TBL] [Abstract][Full Text] [Related]
25. Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus. Tsukaguchi H; Matsubara H; Inada M Kidney Int; 1995 Aug; 48(2):554-62. PubMed ID: 7564126 [TBL] [Abstract][Full Text] [Related]
26. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. Yokoyama K; Yamauchi A; Izumi M; Itoh T; Ando A; Imai E; Kamada T; Ueda N J Am Soc Nephrol; 1996 Mar; 7(3):410-4. PubMed ID: 8704106 [TBL] [Abstract][Full Text] [Related]
27. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2. Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808 [TBL] [Abstract][Full Text] [Related]
28. Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus. Wang L; Guo W; Fang C; Feng W; Huang Y; Zhang X; Liu M; Cui J Sci Rep; 2021 May; 11(1):11057. PubMed ID: 34040143 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist. Makita N; Sato T; Yajima-Shoji Y; Sato J; Manaka K; Eda-Hashimoto M; Ootaki M; Matsumoto N; Nangaku M; Iiri T J Biol Chem; 2016 Oct; 291(43):22460-22471. PubMed ID: 27601473 [TBL] [Abstract][Full Text] [Related]
33. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. van Lieburg AF; Verdijk MA; Schoute F; Ligtenberg MJ; van Oost BA; Waldhauser F; Dobner M; Monnens LA; Knoers NV Hum Genet; 1995 Jul; 96(1):70-8. PubMed ID: 7607658 [TBL] [Abstract][Full Text] [Related]
34. Nephrogenic diabetes insipidus due to a novel AVPR2 mutation. Sakallioglu O; Tascilar ME; Kalman S; Cheong HI; Atay AA J Pediatr Endocrinol Metab; 2009 Feb; 22(2):187-9. PubMed ID: 19449677 [TBL] [Abstract][Full Text] [Related]
35. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826 [TBL] [Abstract][Full Text] [Related]
36. Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus. Erdélyi LS; Balla A; Patócs A; Tóth M; Várnai P; Hunyady L Mol Endocrinol; 2014 May; 28(5):634-43. PubMed ID: 24628417 [TBL] [Abstract][Full Text] [Related]
37. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant. Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187 [TBL] [Abstract][Full Text] [Related]
38. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family. Yamashita S; Hata A; Usui T; Oda H; Hijikata A; Shirai T; Kaneko N; Hata D J Pediatr Endocrinol Metab; 2016 May; 29(5):591-6. PubMed ID: 26974133 [TBL] [Abstract][Full Text] [Related]
39. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature. Ding C; Beetz R; Rittner G; Bartsch O Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219 [TBL] [Abstract][Full Text] [Related]
40. A Novel Mutation in the Çelebi Tayfur A; Karaduman T; Özcan Türkmen M; Şahin D; Çaltık Yılmaz A; Büyükkaragöz B; Buluş AD; Mergen H J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):350-356. PubMed ID: 29991464 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]